Jiao Fuyong, Jindal Ankur Kumar, Pandiarajan Vignesh, Khubchandani Raju, Kamath Nutan, Sabui Tapas, Mondal Rakesh, Pal Priyankar, Singh Surjit
Children's Hospital, Shaanxi Provincial People's Hospital of Xian, Jiaotong Univeristy, China.
Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, PGIMER, Chandigarh, India.
Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201721. doi: 10.21542/gcsp.2017.21.
Kawasaki disease (KD) is recognized as a leading cause of acquired heart disease in children in developed countries. Although global in distribution, Japan records the highest incidence of KD in the world. Epidemiological reports from the two most populous countries in the world, namely China and India, indicate that KD is now being increasingly recognized. Whether this increased reporting is due to increased ascertainment, or is due to a true increase in incidence, remains a matter of conjecture. The diagnosis and management of KD in developing countries is a challenging proposition. In this review we highlight some of the difficulties faced by physicians in managing children with KD in resource-constrained settings.
川崎病(KD)被认为是发达国家儿童后天性心脏病的主要病因。尽管其分布具有全球性,但日本的KD发病率在世界上是最高的。来自世界上两个人口最多的国家,即中国和印度的流行病学报告表明,KD现在越来越受到认可。这种报告增加是由于确诊率提高,还是由于发病率的真正上升,仍是一个推测的问题。在发展中国家,KD的诊断和管理是一项具有挑战性的任务。在这篇综述中,我们强调了在资源有限的环境中,医生在管理KD患儿时面临的一些困难。